StockData
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. (RKDA) stock

RKDANasdaqBeveragesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.19−0.02 (-11.19%)

Close on Nov 16, 2026Market cap $466.42KP/E –Yield –

Arcadia Biosciences ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Arcadia Biosciences's ebitda for the twelve months ending Sep 30, 2019 was -$19.58M. For fiscal 2018 it was -$16.72M. The highest annual figure on record is -$14.04M in fiscal 2017.

Annual ebitda

PeriodPeriod endValueChange
FY2018Dec 31, 2018-$16.72M–
FY2017Dec 31, 2017-$14.04M–
FY2016Dec 31, 2016-$18.32M–
FY2015Dec 31, 2015-$15.27M–
FY2014Dec 31, 2014-$14.80M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2019Sep 30, 2019-$6.14M–
Q2 FY2019Jun 30, 2019-$4.94M–
Q1 FY2019Mar 31, 2019-$4.18M–
Q4 FY2018Dec 31, 2018-$4.32M–
Q3 FY2018Sep 30, 2018-$4.07M–
Q2 FY2018Jun 30, 2018-$4.53M–
Q1 FY2018Mar 31, 2018-$3.79M–
Q4 FY2017Dec 31, 2017-$2.94M–
Q3 FY2017Sep 30, 2017-$3.55M–
Q2 FY2017Jun 30, 2017-$3.67M–
Q1 FY2017Mar 31, 2017-$3.88M–
Q4 FY2016Dec 31, 2016-$5.39M–
Q3 FY2016Sep 30, 2016-$3.85M–

More Arcadia Biosciences figures

See a number that looks wrong?